GRX is a mutual fund — prices shown are end-of-day NAV. Analyst ratings, insider activity, and 13F data apply to individual stocks, not funds.
The Gabelli Healthcare & Wellness Trust
GRX
NYSE·Financial Services·Asset Management·Mkt cap $135.9M
$10.03
▼ -0.59%
P/E
74.79
Mkt Cap
$135.9M
52-Wk Range
$8.80–$10.20
52-Week Range
$8.80 - $10.20
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
No thesis available for this stock yet.
Smart-money signal
Who's buying GRX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Most recent quarter reported revenue of $5.3M (-38% YoY). Reported EPS of $0.25. Gross margin 97.8%.
Reported EPS · last 4Q
Q4 25
$0.25
Q2 25
-$0.10
Q4 24
$0.05
Q2 24
-$0.07
Revenue trend · last 8Q
—
—
-76%
+77%
+359%
-25%
+38%
-38%
Q2 22
Q4 22
Q2 23
Q4 23
Q2 24
Q4 24
Q2 25
Q4 25
$5.9M
$6.5M
$1.4M
$11.5M
$6.4M
$8.7M
$8.9M
$5.3M
Margins · last 8Q
Gross
97.8%
Operating
91.7%
Profit
71.5%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How GRX stacks vs Asset Management
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related